Artificial Intelligence
Victory Square Technologies CEO Issues Future Forecast Letter to Shareholders
![](https://roboticulized.com/wp-content/uploads/2021/03/victory-square-technologies-ceo-issues-future-forecast-letter-to-shareholders.png)
“Last year created unprecedented challenges, but also validated our core philosophy at Victory Square: the best entrepreneurs always build towards the future, rather than just addressing the market demands of today.”
VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“Victory Square”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that provides investors access to a diverse portfolio of next generation internet companies in key sectors including: digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to issue a letter to shareholders from CEO, Shafin Diamond Tejani.
The Company recently released a Quarterly Corporate Update, which included the following highlights:
Victory Square is pleased to issue a future forecast letter to shareholders from CEO, Shafin Diamond Tejani.
Dear Shareholders,
I’m excited to share Victory Square’s Future Forecast, with the trends and technologies that will shape the world and guide our investments over the coming decade. First, a story. We initially heard about entrepreneur Felipe Peixoto in 2017. At the time, he was running a small company called SafeTest Diagnóstocos, in the southeastern corner of Brazil. He spent his days developing tools to detect infectious tropical diseases endemic to the region like Zika, dengue, and yellow fever.
But to us, Peixoto was already living in the future — and founders who live in the future have the best chance of winning big. We knew the world would one day come calling for personal diagnostic technologies like the ones SafeTest was developing. So we invested. That moment arrived sooner than even we anticipated, as the coronavirus spread across the globe in 2020. SafeTest quickly built an affordable, 15-minute test for Covid-19 that’s become a critical weapon in fighting the disease.
Last year created unprecedented challenges, but also validated our core philosophy at VST: the best entrepreneurs always build towards the future, rather than just addressing the market demands of today. The crisis fast-forwarded the need for innovative solutions and accelerated waves of emerging technologies. SafeTest and other seeds we planted in prior years ripened quickly, and many of our portfolio companies achieved major goals sooner than expected. In fact, 2020 represented a record year for VST.
But this is just the beginning. We continue to live in the future. As all-consuming as the present moment may seem, our eyes are fixed firmly on what’s next. With that in mind, here are the trends and technologies that will shape the world and guide our investments over the coming decade.
A radically new landscape There are certain innovations that reshape the world around them, unleashing economic opportunity inconceivable beforehand. In the 1700s, this was the steam engine. In the 1800s, railways made the world smaller. In the 1900s, cars, phones and electricity converged to remake society. More recently, computers and the internet have unlocked untold trillions in value.
But this pales in comparison to what lies ahead. In the future, we will experience far greater disruption, much of it driven by five inter-related innovation platforms, as highlighted by investment advisor and CEO of ARK Invest Cathie Wood: artificial intelligence, robotics, energy storage, genomics, and blockchain.
Artificial intelligence is the ability of machines to “think.” The next phase of AI, deep learning, will enable machines to learn from and adapt to their environments, rather than operate on man-made algorithms. Robotics will become more like the robots of science-fiction, making decisions rather than just obeying simple commands. Energy storage will enable the world to capture power from intermittent renewable sources like solar and wind. Genomics will give us the power to read and rewrite DNA — the blueprints of all living things — so we can cure disease, save species, and end hunger. Blockchain, the decentralized ledger system behind crypto-currencies, will enable people to share information and make transactions more securely.
Each of these platforms is powerful on its own, transcending individual sectors and crossing geographic boundaries. But together, their impact is staggering. In the years ahead, they will converge, multiplying the effects of each other. AI will catalyze innovations in other platforms, powering advances in automation and genomic discoveries. As the flywheel accelerates, we’ll see driverless cars, personalized medicine and machines that diagnose and repair themselves, to name a few technologies set to go mainstream.
But there’s more. Driving these advances will be the biggest push factor the world has ever known: the survival of our species. Much of the innovation in the decade ahead must, of necessity, be directed towards solving the climate emergency. This crisis endangers the world and every living thing in it. Stopping it will demand trillions of dollars in investment across many sectors, and commandeer as much ingenuity as humanity can muster. The stakes, and the market opportunities, are enormous. An unwavering mission
VST will be at the forefront of these vast global transformations. But, critically, the philosophy that guides our investments in the decade ahead will remain unchanged: identifying what comes next and finding accessible entry points to capitalize on the future, now.
It was this approach that informed our early bets over the past decade on future-forward sectors as diverse as gaming, e-sports, blockchain, AI, AR/VR, and health technologies. We’ve seen those bear fruit in the hypergrowth of our portfolio companies Immersive Tech, FansUnite, Game On, Victory Square Health, and many more.
As we look forward, that same philosophy will continue to set us apart. It’s supported by a core set of underlying principles.
A roadmap for the next decade
So what does all this look like in practice at VST? We’ve locked our sights onto three main target areas over the next decade that we believe will improve people’s lives: solving the climate crisis, driving the genomic revolution forward, and creating the next-generation of the internet. Climate change isn’t just an environmental issue. Clean energy and decarbonization will bring enormous economic rewards for companies that can build solutions. Clean tech alone presents a $26-trillion opportunity globally. In my own backyard, British Columbia has banned fossil-fuel-burning cars and trucks by 2040, joining numerous jurisdictions around the world moving towards zero-emissions transport. That’s driven electric car-maker Tesla to become one of the most valuable companies in the world, and it’s also spurred demand for sustainably sourced clean-tech materials like graphite for batteries. VST sees enormous potential in climate tech, as these innovations transcend sectors and become woven into the fabric of our daily lives.
Equally promising is genomics, the use of DNA sequencing technology and tools like CRISPR and molecular diagnostics to transform everything from healthcare and pharmaceuticals to agriculture. Right now, genomics are the tip of humanity’s spear in the fight against diseases like Covid-19, as scientists use gene sequencing to read and track changes in the coronavirus’ genetic code and create new mRNA-based vaccines. Genomics are also key weapons in the battle against cancer, with technologies like liquid biopsies helping detect the disease more quickly and less invasively than before. VST is heavily investing in diagnostics and telemedicine, and we’re looking to expand our healthcare portfolio with new genomic technologies.
Finally, we’re already deeply invested in next-generation internet technologies — innovations changing how the world sells goods, crunches data, communicates and plays online. The events of the past year have only driven home how much of our lives are mediated by the internet. It’s abundantly clear that more and more of our affairs will be conducted online in the years ahead, bringing with it the need for better and more efficient tools. VST is well positioned to expand here on our current investments in blockchain solutions, AR/VR, cloud infrastructure, and online gaming.
Last year brought incredible disruptions in the form of a world-consuming health crisis. Yet these changes are less an anomaly than a sign of things to come. The truism, “Change has never been this fast; it will never be this slow again,” has never been more apt. But while the future is uncertain, the challenges ahead are plain to see and, in many respects, timeless: health and safety, the desire to communicate and play, the need to eat and work and thrive. VST knows that living in the future means finding creative new ways to solve these timeless needs. At root, we’re committed to investing in technologies that address these fundamental human issues and help us get to a brighter 2030 together.
Sincerely, Shafin Diamond Tejani Check out VictorySquare.com and sign up to VST’s official newsletter at VictorySquare.com/newsletter.
For further information about the Company, please contact:
Investor Relations Contact – Edge Communications Group Media Relations Contact – Howard Blank, Director ABOUT VICTORY SQUARE TECHNOLOGIES INC.
Victory Square (VST) builds, acquires and invests in promising startups, then provides the senior leadership and resources needed for fast-track growth.
VST’s sweet spot is cutting-edge tech that’s shaping the 4th Industrial Revolution. Our corporate portfolio consists of 20 global companies using AI, VR/AR, and blockchain to disrupt sectors as diverse as fintech, insurance, health and gaming.
What we do differently for startups
VST isn’t your ordinary investor. With real skin in the game, we’re committed to ensuring each company in our portfolio succeeds. Our secret sauce starts with selecting startups that have real solutions, not just ideas. We pair you with senior talent in product, engineering, customer acquisition and more. Then we let you do what you do best — build, innovate and disrupt. In 24-36 months, you’ll scale and be ready to monetize. What we do differently for investors
VST is a publicly-traded company headquartered in Vancouver, Canada, and listed on the Canadian Securities Exchange (VST), Frankfurt Exchange (6F6) and the OTCQX (VSQTF). For investors, we offer early-stage access to the next unicorns before they’re unicorns. Our portfolio represents a uniquely liquid and secure way for investors to get access to the latest cutting-edge technologies. Because we focus on market-ready solutions that scale quickly, we’re able to provide strong and stable returns while also tapping into emerging global trends with big upsides. For more information, please visit www.victorysquare.com
Cautionary Disclaimers
This news release shall not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction. Any securities referred to herein have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to a U.S. Person absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.
This news release shall not constitute an offer to sell or the solicitation of an offer to buy the securities, nor shall there be any sale of the securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities to be offered have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or under any U.S. state securities laws, and may not be offered, sold, directly or indirectly, or delivered within the United States except in certain transactions exempt from the registration requirements of the U.S. Securities Act and all applicable U.S. state securities laws. This release does not constitute an offer to sell or a solicitation of an offer to buy such securities in the United States, Canada or in any other jurisdiction where such offer, solicitation or sale is unlawful. Forward Looking Statement
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to the outlook of the business of Victory Square, including, without limitation, statements relating to completion of the transaction, execution of business strategy, future performance and future growth, business prospects and opportunities of Victory Square and its related subsidiaries, and other factors beyond our control. Such forward-looking statements may, without limitation, be preceded by, followed by, or include words such as “believes”, “expects”, “anticipates”, “estimates”, “intends”, “plans”, “continues”, “project”, “potential”, “possible”, “contemplate”, “seek”, “goal”, or similar expressions, or may employ such future or conditional verbs as “may”, “might”, “will”, “could”, “should” or “would”, or may otherwise be indicated as forward-looking statements by grammatical construction, phrasing or context. All statements other than statements of historical facts contained in this news release are forward-looking statements. Forward-looking information is based on certain key expectations and assumptions made by the management of Victory Square, including, but not limited to, the CSE approving the transaction. Although Victory Square believes that the expectations and assumptions on which such forward looking information is based are reasonable, undue reliance should not be placed on them because Victory Square can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements contained in this news release are made as of the date of this news release. Victory Square disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws. The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Chairman and Chief Executive Officer
Victory Square Technologies
Email: [email protected]
Telephone: 604 283-9166
Email: [email protected]
Telephone: 604-928-6066 (media only)
Artificial Intelligence
MGI Tech and SeqOne Partner to Advance End-to-end Genomic Analysis
![mgi-tech-and-seqone-partner-to-advance-end-to-end-genomic-analysis](https://roboticulized.com/wp-content/uploads/2024/06/150213-mgi-tech-and-seqone-partner-to-advance-end-to-end-genomic-analysis.jpg)
PARIS, June 17, 2024 /PRNewswire/ — MGI (MGI Tech Co., Ltd. or its subsidiaries, together referred to MGI), a company committed to building core tools and technologies that drive innovation in life science, today announced the collaboration with SeqOne, a leading provider of AI-driven genomic decision support software, to develop and validate end-to-end genomic analysis solutions from sample to report tailored to the needs of Human Genetics and Pathology labs worldwide.
This collaboration between MGI and SeqOne encompasses three distinct initiatives:
Validating an end-to-end, automated, cost-effective solution for HRD signature with MGI DNBSEQ-G99
The collaboration between a Pathology Reference Lab in Spain, Agilent Technologies, MGI, and SeqOne aims to technically validate a routine workflow leveraging Agilent panels, Magnis lib prep automation, MGI DNBSEQ-G99, and SeqOne somaHRD, a clinically validated HRD signature solution, on 96 samples.
This end-to-end solution for pathology molecular labs will enable high-quality, efficient, and flexible HRD testing worldwide, including Genomic Instability score and BRCA testing.
Enabling and validating SeqOne tertiary analysis solution compatible with MGI Megabolt for Germline Panels, Whole Exome and Whole Genome
MegaBOLT bioinformatics analysis accelerator, self-developed and MPS-concentrated hardware accelerating system by MGI, is set to ensure seamless integration and compatibility with SeqOne’s AI-powered variants identification and analysis solution.
The collaboration aims to combine MegaBOLT and the SeqOne Platform to deliver a versatile, cost-effective, intuitive, and time-saving solution from sample to report, particularly attractive for high-throughput Human Genetics labs.
Validating SeqOne CE-IVD Platform for Germline and Somatic analysis for use with MGI sequencers in routine diagnostics
This technical validation project aims to evaluate the compatibility of the SeqOne Platform with MGI sequencing data. It will validate variant calling performances on a set of reference control samples in terms of QC, sensitivity and precision.
“We are thrilled to announce our collaboration with SeqOne. By combining MGI’s cutting-edge sequencing technology with SeqOne’s innovative genomic analysis Platform, we are poised to deliver real insights and solutions for personalized healthcare,” said Dr. Yong Hou, General Manager of MGI Europe and Africa. “This collaboration underscores our commitment to advancing genomic research and providing clinicians with the tools they need to offer tailored treatments to their patients.”
“This partnership with MGI strongly supports SeqOne’s mission to broaden access to sophisticated genomic analysis, aiming to improve healthcare outcomes,” said Martin Dubuc, CEO, SeqOne. “Molecular laboratories globally are exploring how MGI’s sequencing and bioinformatics technologies can advance next-generation sequencing (NGS) research and diagnostics. We are eager to integrate SeqOne’s CE-IVD Platform with MGI’s offerings, enhancing the quality, sensitivity, and precision of bioinformatic analyses.”
About MGI
MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries. Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and have established research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. To learn more, please visit https://en.mgi-tech.com/, LinkedIn, X, and YouTube.
About SeqOne
SeqOne is a fast-growing deep-tech company focused on turning genomic data into medically- actionable insights in oncology and rare and inherited diseases. Our vision is to make personalized healthcare a reality for every patient, everywhere. We are committed to democratizing access to advanced genomic insights, enabling labs of any size, in any location, to offer affordable personalized medicine solutions to patients at scale. We integrate cutting-edge AI and big data technologies to redefine genetic data analysis. Our CE-IVD Platform provides time saving, flexible, and cost-effective decision support, empowering decentralized laboratories worldwide to deliver precision diagnostics.The company has won numerous awards, including the iLab award and the ARC Cancer Foundation’s Hélène Stark prize. Investors include Elaia, IRDI Capital Investissement, Merieux Equity Partners, Omnes, and Software Club. To learn more, please visit www.seqone.com and Linkedin.
Logo – https://mma.prnewswire.com/media/2329841/MGI__Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/mgi-tech-and-seqone-partner-to-advance-end-to-end-genomic-analysis-302173987.html
Artificial Intelligence
Symphony Talent’s Award-Winning Full-Funnel Talent Acquisition Portfolio Earns Strategic Challenger Status on Fosway 9-Grid™ for Third Consecutive Year
![symphony-talent’s-award-winning-full-funnel-talent-acquisition-portfolio-earns-strategic-challenger-status-on-fosway-9-grid™-for-third-consecutive-year](https://roboticulized.com/wp-content/uploads/2024/06/150215-symphony-talents-award-winning-full-funnel-talent-acquisition-portfolio-earns-strategic-challenger-status-on-fosway-9-grid-for-third-consecutive-year.jpg)
NEW YORK and LONDON, June 17, 2024 /PRNewswire/ — Symphony Talent, a global leader in recruitment marketing technology and employer brand services, has been named a Strategic Challenger on the 2024 Fosway 9-Grid™ for Talent Acquisition for the third consecutive year, demonstrating Symphony Talent’s consistent dedication to providing cutting-edge solutions that drive game-changing results for talent acquisition teams worldwide.
“From rapidly evolving technologies to shifting candidate expectations, the TA industry faces many challenges,” says Sven Elbert, Head of Analyst Services at Fosway Group. “A full-funnel talent acquisition solution — that seamlessly aligns employer branding, technology and data analytics to the candidate journey — is essential to address these complexities. Symphony Talent provides a robust framework for meeting the diverse needs of complex, global enterprise-scale clients.”
Empowering TA Teams with Full-Funnel Solutions
Symphony Talent’s extensive portfolio of talent acquisition solutions, including its Brand and Creative Services, Programmatic Media Advertising, Career Sites, CRM, and Assessments, drive outstanding client results by addressing every stage of the talent acquisition funnel. Over 700 global clients leverage Symphony Talent’s innovative technologies and strategic expertise, achieving significant outcomes, such as:
Cutting administrative recruiting tasks by 65%Spending 70% less time managing media spendReducing time spent qualifying talent by 60%Decreasing cost per hire by 25%Filling open positions 30% fasterEnsuring quality hires with a 15% reduction in employee turnover”We are honored to be recognized as a Strategic Challenger on the Fosway 9-Grid™ for the third year in a row,” says Kermit Randa, CEO of Symphony Talent. “This achievement highlights our ongoing commitment to connect clients with innovative, high-impact solutions and data that empower them to navigate the complexities of today’s talent landscape and confidently convert candidates to co-workers.”
Highlights of Symphony Talent’s Achievement:
Innovation and Leadership: Symphony Talent’s continuous recognition as a Strategic Challenger is a testament to its unwavering commitment to innovation and leadership in the talent acquisition industry. The company’s comprehensive suite of solutions, including the award-winning SFX platform, integrates brand and creative services with recruitment marketing technology to streamline the hiring process and enhance candidate experience.Client-Centric Approach: Symphony Talent’s focus on understanding and addressing its clients’ evolving needs has been pivotal in maintaining its strategic position. Symphony Talent ensures clients achieve tangible and measurable outcomes by offering personalized support, detailed implementation schedules, and optimization workgroups.Adaptation to Market Trends: With a deep understanding of the current market dynamics and the challenges faced by talent acquisition teams, Symphony Talent has continuously adapted its offerings to meet these demands. This includes leveraging AI and automation to enhance productivity and providing data-driven insights to optimize recruitment strategies.About the Fosway 9-Grid™
Fosway Group is Europe’s #1 HR industry analyst. The Fosway 9-Grid™ provides a unique assessment of the principal learning and talent supply options available to organisations in EMEA. The analysis is based on extensive independent research and insights from Fosway’s Corporate Research Network of over 250 organisations, including BP, HSBC, PwC, RBS, Sanofi, Shell, and Vodafone. Visit the Fosway website at www.fosway.com.
About Symphony Talent
Symphony Talent is a recruitment marketing technology and employer brand services company that helps talent acquisition teams execute strategic, innovative candidate interactions. Our award-winning, synergistic technology and brand solutions are designed to deliver outcomes — from reach to retention — that unlock a competitive advantage for clients across the globe, including the world’s leading brands. Visit symphonytalent.com to learn more.
Logo – https://mma.prnewswire.com/media/2287879/ST_Logo_Single_Line_Full_Color__12_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/symphony-talents-award-winning-full-funnel-talent-acquisition-portfolio-earns-strategic-challenger-status-on-fosway-9-grid-for-third-consecutive-year-302173377.html
Artificial Intelligence
Darwinbox named as a Customers’ Choice in the 2024 Gartner® Peer Insights™ Voice of the Customer for Cloud HCM Suites Report for Enterprises with 1,000+ Employees
![darwinbox-named-as-a-customers’-choice-in-the-2024-gartner-peer-insights™-voice-of-the-customer-for-cloud-hcm-suites-report-for-enterprises-with-1,000+-employees](https://roboticulized.com/wp-content/uploads/2024/06/150209-darwinbox-named-as-a-customers-choice-in-the-2024-gartner-peer-insights-voice-of-the-customer-for-cloud-hcm-suites-report-for-enterprises-with-1000-employees.jpg)
DUBAI, UAE, June 17, 2024 /PRNewswire/ — Darwinbox, a global leader in cloud-based HCM solutions, today announced that it has been distinguished as a Customers’ Choice in the 2024 Gartner® Peer Insights™ Voice of the Customer for Cloud HCM Suites for 1,000+ Employee Enterprises.
The Gartner® Peer Insights™ Customers’ Choice distinction is based on feedback and ratings from end-user professionals with experience using the product or service. As of 31 January 2024, Darwinbox received an overall rating of 4.8 out of 5 stars across 141 reviews.
“We believe this distinction, for the third consecutive year, reflects our unwavering commitment to our customers and their success, as well as our dedication to excellence and innovation in the HCM space,” says Jayant Paleti, co-founder, Darwinbox.
Darwinbox has been named a Customers’ Choice for both Large Enterprise (1B – 10B USD) and Midsize Enterprise (50M – 1B USD) segments, showcasing its robust capabilities in handling large-scale operations and its widespread appeal across various business sizes. This recognition underscores the platform’s popularity, driven by its powerful configurability, intuitive design, and agility. An impressive 98% of customers rated Darwinbox 4-stars or higher, highlighting the overwhelming satisfaction with the product.
Furthermore, Darwinbox is recognized as the most customer-friendly enterprise-grade HCM solution globally. The platform distinguishes itself through its ease of implementation and integration, prompt vendor responses, and exceptional technical support, demonstrating Darwinbox’s dedication to quick service and client satisfaction. Notably, 94% of its customers have expressed their willingness to recommend Darwinbox, demonstrating its significant impact and reliability in the enterprise tech landscape.
“What I love is when we need support, the customer service is top-notch – always responsive, solution makers, and always helpful,” HR Business Partner, Media Industry
“Darwinbox has been able to cater to our needs given our diverse business structures and differences in processes,” HR Lead, Manufacturing Sector
Read more reviews
About Darwinbox:
Darwinbox is a leading SaaS-based HR technology platform, empowering organisations to automate HR processes and elevate the employee experience. Rated the highest globally among HCM players on Gartner’s customer review platform, Peer Insights, Darwinbox is trusted by 900+ global enterprises with more than 2.5 million employees spread across 116+ countries.
Photo: https://mma.prnewswire.com/media/2438686/Darwinbox_Voice_of_the_Customer.jpg
View original content:https://www.prnewswire.co.uk/news-releases/darwinbox-named-as-a-customers-choice-in-the-2024-gartner-peer-insights-voice-of-the-customer-for-cloud-hcm-suites-report-for-enterprises-with-1-000-employees-302173015.html
-
Artificial Intelligence7 days ago
ADP Rings NASDAQ Opening Bell Celebrates 75 Years at the Forefront of Payroll & HR Innovation
-
Artificial Intelligence3 days ago
Borderless AI & Cohere team up to build a custom-trained AI model for HR professionals, taking on Deel and Remote.com
-
Artificial Intelligence7 days ago
TraceLink Partners with Genpact to Expand Delivery of Digital Supply Chain Innovation for Healthcare and Life Sciences Sectors
-
Artificial Intelligence7 days ago
Empowering data practitioners will help shape generative AI deployment for enterprise, says new MIT Technology Review Insights research report
-
Uncategorized6 days ago
Hughes Europe Expands into Military, Defence & Government Sectors with Launch of Konnect VHTS Services in Collaboration with Telespazio
-
Uncategorized4 days ago
AI Could Transform UK’s Public Finances as Labour Touts Gains
-
Artificial Intelligence3 days ago
LoRa and LoRaWAN IoT Market worth $32.7 billion by 2029- Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence3 days ago
Complyport’s new AI tool – ViCA.Chat – set to revolutionise compliance support services